Clinical Trials Sponsored by Nektar Therapeutics
Total 6326 results
-
Nektar TherapeuticsCompletedMultiple Myeloma | Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
Nektar TherapeuticsCompletedBreast Cancer | MetastasisUnited States, Australia, Belgium, Canada, France, Israel, Italy, Portugal, Spain, United Kingdom
-
Nektar TherapeuticsCompletedOvarian Cancer | TumorUnited States, Belgium, United Kingdom
-
Nektar TherapeuticsCompletedColorectal Cancer | TumorUnited States
-
Nektar TherapeuticsCompletedLow Back Pain | Chronic PainUnited States
-
Nektar TherapeuticsCompletedBreast Cancer | TumorUnited States, Belgium, United Kingdom
-
Nektar TherapeuticsCompletedAdvanced or Metastatic Solid Tumors in Patients With Hepatic ImpairmentUnited States
-
Nektar TherapeuticsRecruiting
-
Nektar TherapeuticsCompletedCervical Cancer | Colorectal Cancer | Head and Neck Squamous Cell Carcinoma | Anal Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Nektar TherapeuticsTerminatedMelanoma | Sarcoma | Renal Cell Carcinoma | Colorectal Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Merkel Cell CarcinomaUnited States
-
Nektar TherapeuticsCompletedColorectal CancerUnited States, Belgium, Germany, India, Spain, United Kingdom
-
Nektar TherapeuticsTerminatedModerate to Severe Chronic PainUnited States
-
Nektar TherapeuticsCompletedMetastatic Breast Cancer | Locally Recurrent Breast CancerUnited States, Spain, Korea, Republic of, Canada, United Kingdom, Germany, France, Netherlands, Belgium, Italy, Russian Federation
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisUnited States, Canada
-
Nektar TherapeuticsRecruitingNon-Hodgkin Lymphoma | Relapsed/Refractory Diffuse Large B-cell LymphomaUnited States
-
Nektar TherapeuticsCompletedCovid-19 | Coronavirus Disease 2019United States
-
Nektar TherapeuticsTerminatedNon-Small Cell Lung CancerUnited States, Germany, Spain, Australia, France
-
Nektar TherapeuticsCompletedOsteoarthritis of the KneeUnited States
-
Nektar TherapeuticsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Nektar TherapeuticsCompletedMalignant Solid TumorUnited States, Belgium
-
Nektar TherapeuticsCompletedLow Back Pain | Chronic PainUnited States
-
Nektar TherapeuticsCompletedAdvanced Cancer | Metastatic Solid TumorsUnited States
-
BayerNektar TherapeuticsCompleted
-
BayerNektar TherapeuticsCompleted
-
BayerNektar TherapeuticsCompletedPneumonia, BacterialKorea, Republic of, Taiwan, United States, Canada, Philippines, Turkey, Thailand, Australia, Mexico, Colombia, Czechia, Brazil
-
AstraZenecaNektar TherapeuticsCompletedOpioid Induced Constipation (OIC)United States
-
Nektar TherapeuticsImaginAb, Inc.Withdrawn
-
AbelZeta, Inc.Nektar TherapeuticsRecruiting
-
Solvay PharmaceuticalsNektar TherapeuticsCompletedMigraine Without Aura | Migraine With AuraUnited States
-
PfizerSanofi; Nektar TherapeuticsCompletedDiabetes Mellitus, Type 2United States, Canada
-
Bristol-Myers SquibbNektar TherapeuticsCompletedMelanomaCanada, Australia, France, Italy, Brazil, United States, Argentina, Austria, Belgium, Chile, Czechia, Finland, Germany, Greece, Ireland, Israel, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden and more
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, France, Australia, Italy, Greece, Israel, Russian Federation, New Zealand, Austria, United Kingdom, Netherlands, Portugal, Poland, Czechia, Romania
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Nektar TherapeuticsBristol-Myers SquibbCompletedNeoplasm Metastasis | Urinary Bladder NeoplasmUnited States, Spain, United Kingdom, Belgium, Canada, Australia, France, Italy, Greece, Germany, Portugal, Argentina, Israel, Russian Federation, Turkey, Mexico, Finland, Netherlands
-
Bristol-Myers SquibbNektar TherapeuticsTerminatedEwing Sarcoma | Ependymoma | Medulloblastoma | Neuroblastoma | Rhabdomyosarcoma | High-grade Glioma | Leukemia and Lymphoma | Miscellaneous Brain Tumors | Miscellaneous Solid Tumors | Relapsed, Refractory Malignant NeoplasmsUnited States, Australia, France, Germany, Italy, Spain
-
Nektar TherapeuticsBristol-Myers SquibbCompletedMelanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Urothelial Carcinoma | HR+/HER2- Breast CancerUnited States, Spain, Canada, France, Italy, Belgium, Poland, United Kingdom
-
Calithera Biosciences, IncNektar TherapeuticsWithdrawnLymphoma, Non-HodgkinUnited States, Canada
-
Bristol-Myers SquibbNektar TherapeuticsCompletedRenal Cell CarcinomaUnited States, Argentina, Brazil, Canada, France, Germany, Mexico, Russian Federation
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedRenal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States, Argentina, Brazil, Australia, Singapore, New Zealand, Russian Federation, Mexico, Peru, Chile
-
Stony Brook UniversityNektar TherapeuticsCompletedVentilator Associated Pneumonia | Respiratory Infection | TracheobronchitisUnited States
-
Nykode Therapeutics ASANektar Therapeutics; Vaccibody ASCompletedLocally Advanced or Metastatic Solid TumoursGermany
-
M.D. Anderson Cancer CenterNektar TherapeuticsRecruitingLung CancerUnited States
-
Fred Hutchinson Cancer CenterNektar TherapeuticsRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Recurrent Grade 3b Follicular Lymphoma | Refractory Grade 3b Follicular... and other conditionsUnited States
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Joel NealNektar TherapeuticsCompletedTumors Metastatic to Brain | Stage IV Non-small Cell Lung Cancer (NSCLC) | Recurrent Non-small Cell Lung Cancer (NSCLC) | Extensive-stage Small Cell Lung Cancer (SCLC) | Recurrent Small Cell Lung Cancer (SCLC) | Metastatic Breast Cancer (mBC)United States
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsEli Lilly and CompanyCompletedSystemic Lupus ErythematosusUnited States, Spain, Japan, India, Israel, Korea, Republic of, Taiwan, Australia, Puerto Rico, Argentina, Romania, Canada, Germany, Russian Federation, Mexico, Ukraine, Poland, Czechia, Hungary
-
University of Wisconsin, MadisonNektar TherapeuticsTerminatedHead and Neck CancerUnited States
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsEli Lilly and CompanyCompletedSystemic Lupus ErythematosusUnited States